Last Funding Date: 2021-11-09
Investors Number: 21.0
Industry: Early Drug Development
Last Funding Type: Series B
Headquarters: Cambridge, Massachusetts, United States
Total Funding: 230600000.0
Funding Status: Early Stage Venture
Employee Number: 11-50
Technology: Biopharma, Biotechnology, Life Science
Estimated Revenue: $1M to $10M
Founded Date: 2016-01-01